Impaired autonomic function and somatosensory disturbance in patients with treated autoimmune thyroiditis, 2024, Bojana Bazika-Gerasch et al

Discussion in 'Other health news and research' started by Mij, Jun 9, 2024.

  1. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    8,606
    Abstract
    Despite treatment with levothyroxine, hypothyroidism and autoimmune thyroiditis (AIT) may be associated with reduced quality of life (QoL), an enigmatic condition referred to as "syndrome T". Peripheral neuropathy, described in untreated thyroid disease, could be a contributing mechanism.

    We analyzed autonomic and somatosensory function in 29 patients with AIT and treated hypothyroidism and 27 healthy volunteers. They underwent heart rate variability (HRV) analysis and quantitative sensory testing (nā€‰=ā€‰28), comprising 13 parameters of small and large nerve fibre function and pain thresholds. Autonomic cardiovascular function was assessed in rest, deep respiration and orthostasis. Additionally, biomarkers for autoimmunity and thyroid function were measured.

    Anxiety, depression and QoL were assessed using validated questionnaires. 36% of the patients showed at least one sign of somatosensory small or large fibre dysfunction. 57% presented with mild hyperalgesia to at least one stimulus.

    Several markers of autonomic function and some detection thresholds were related to the antibody titres. Anxiety, depression scores and QoL correlated to antibody titres and HRV measures.

    Autonomic and somatosensory dysfunction indicate that in treated hypothyroidism and AIT a subgroup of patients suffers from neuropathic symptoms leading to impaired QoL. Additionally, mild hyperalgesia as a possible sensitisation phenomenon should be considered a target for symptomatic treatment.

    LINK
     
    Peter Trewhitt and forestglip like this.
  2. Arnie Pye

    Arnie Pye Senior Member (Voting Rights)

    Messages:
    6,179
    Location:
    UK
    forestglip and alktipping like this.

Share This Page